Literature DB >> 11301744

Diagnosis and management of cor triatriatum dexter in a Pyrenean mountain dog and an Akita Inu.

R W Mitten1, G A Edwards, M Rishniw.   

Abstract

Cor Triatriatum Dexter is a rare, congenital cardiac defect in which the right atrium is partitioned into two compartments, effectively creating a triatrial heart. The clinical signs exhibited by the patient usually relate to impeded venous return via the caudal vena cava. The two dogs in this report both displayed ascites from a young age and grew poorly. In both cases the diagnosis was made during echocardiographic examination and was confirmed by angiography. Both dogs were successfully treated by resection of the partitioning membrane within the right atrium, using hypothermia and inflow occlusion to achieve a clear surgical field. Both dogs recovered well, their clinical signs resolved and they have grown to normal adult size.

Entities:  

Mesh:

Year:  2001        PMID: 11301744     DOI: 10.1111/j.1751-0813.2001.tb14572.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  3 in total

1.  Anaesthetic management for balloon dilation of cor triatriatum dexter in a dog.

Authors:  Valentina De Monte; Francesco Staffieri; Domenico Caivano; Antonello Bufalari
Journal:  Acta Vet Scand       Date:  2015-06-10       Impact factor: 1.695

2.  Imperforated cor triatriatum dexter in a dog with concurrent caudal vena cava wall mineralization.

Authors:  Tetyda Paulina Dobak; Gregory Starrak; Kathleen Linn; Elisabeth Christine Roberston Snead
Journal:  Acta Vet Scand       Date:  2017-01-03       Impact factor: 1.695

3.  Combined interventional procedure and cardiopulmonary bypass surgery in a dog with cor triatriatum dexter, patent foramen ovale, and pulmonary stenosis.

Authors:  Federica Marchesotti; Vincenzo Rondelli; Marco Pesaresi; Stefano Nicoli; Tommaso Vezzosi; Edoardo Auriemma; Guido Lanzillo; Andrea Cuccio; Toufic Khouri; Annette Dejong; Oriol Domenech
Journal:  J Vet Intern Med       Date:  2019-08-05       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.